Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD

被引:6
|
作者
Bathini, Lavanya [1 ,2 ]
Jandoc, Racquel [1 ]
Kuwornu, Paul [1 ]
McArthur, Eric [1 ]
Weir, Matthew A. [1 ,2 ,3 ]
Sood, Manish M. [1 ,4 ]
Battistella, Marisa [5 ]
Muanda, Flory T. [1 ,2 ]
Liu, Aiden [1 ]
Jain, Arsh K. [1 ,2 ,3 ]
Garg, Amit X. [1 ,2 ,3 ]
机构
[1] Inst Clin Evaluat Sci, Toronto, ON, Canada
[2] Western Univ, Dept Med, Div Nephrol, London, ON, Canada
[3] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
[4] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada
[5] Univ Toronto, Fac Pharm, Toronto, ON, Canada
关键词
Aged; 80 and over; cefprozil; Cefuroxime; Anti-Bacterial Agents; Cephalexin; Odds Ratio; glomerular filtration rate; Outpatients; Confidence Intervals; Retrospective Studies; renal dialysis; Cephalosporins; Renal Insufficiency; Chronic; Treatment Failure; Risk; hospitalization; Emergency Service; Hospital; ADVERSE DRUG-REACTIONS; CHRONIC KIDNEY-DISEASE; RISK-FACTORS; PREVALENCE; EQUATION;
D O I
10.2215/CJN.10710918
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Current dosing recommendations for cephalosporin antibiotics are on the basis of pharmacokinetic studies and are frequently ignored in practice. This study was undertaken to investigate the clinical outcomes of failing to dose-reduce cephalosporin antibiotics in CKD. Design, setting, participants, & measurements Retrospective cohort study conducted in Ontario, Canada using linkedpopulation-basedhealthcaredatabases. Nine thousandthreehundred forty-sevenoutpatients (median age 83; interquartile range, 77-88 years; 57% women) with an eGFR, 30 ml/min per 1.73 m2 and no prior history of dialysis were dispensed oral cephalexin, cefuroxime, or cefprozil between April of 2007 andMarch of 2016. Two thirds of the patients (6253 of 9347) received a higher than recommended daily dose of cephalexin (>1000 mg), cefuroxime (>500mg), or cefprozil (>500mg). The primary outcome was a hospital encounter (emergency room visit or hospital admission) with a condition listed as a possible side-effect of cephalosporins. Secondary outcomes were antibiotic treatment failure and all-cause mortality. All measures were assessed in the 30 days after cephalosporin initiation. Results Patients who received a higher than recommended dose of a cephalosporin antibiotic were similar in multiple indicators of baseline health to patientswho received a reduced dose. Overall, 6% of patients presented to hospitalwith a possible cephalosporin side-effect, 13% failed antibiotic treatment, and 3% died. Comparedwith a reduced dose, receiving a higher dose of antibiotic was not associatedwith a different rate of side-effects (adjusted odds ratio, 1.00; 95% confidence interval, 0.84 to 1.20), treatment failure (1.01; 0.88 to 1.15), or death (0.99; 0.76 to 1.29). Conclusions In this study we failed to demonstrate any association between the dose of cephalosporin antibiotic administered to elderly patientswithCKDand the risk of side-effects leading to hospitalization, treatment failure, or mortality.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [1] Splenectomy in older adults: indications and clinical outcomes
    Frasier, Lane L.
    Malani, Preeti N.
    Diehl, Kathleen M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (04) : 480 - 484
  • [2] URINARY UROMODULIN AND CLINICAL OUTCOMES IN OLDER ADULTS
    Garimella, Pranav
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 411 - 411
  • [3] Splenectomy in older adults: indications and clinical outcomes
    Lane L. Frasier
    Preeti N. Malani
    Kathleen M. Diehl
    International Journal of Hematology, 2013, 97 : 480 - 484
  • [4] PREDICTING FACTORS OF CLINICAL OUTCOMES IN TRAUMATIZED ADULTS AND OLDER ADULTS
    Suyasith, Pornthip
    Chayaput, Prangtip
    Thosingha, Orapan
    Leveille, Suzanne G.
    Sirikun, Jatuporn
    INNOVATION IN AGING, 2021, 5 : 595 - 595
  • [5] Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD
    Muanda, Flory T.
    Weir, Matthew A.
    Bathini, Lavanya
    Clemens, Kristin K.
    Perkovic, Vlado
    Sood, Manish M.
    McArthur, Eric
    Sontrop, Jessica M.
    Kim, Richard B.
    Garg, Amit X.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1728 - 1739
  • [6] Is Apathy a New Risk Factor for Adverse Health Outcomes Among Older Adults With CKD?
    Burrows, Brett
    Ma, Jessica E.
    Bowling, C. Barrett
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (02) : 133 - 135
  • [7] Clinical Outcomes Related to a Quality Improvement Intervention to Reduce Unnecessary Urinary Catheter Utilization in Hospitalized Older Adults
    Norman, R.
    Ramsden, R.
    Verscheure, L.
    Sinha, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S1 - S1
  • [8] Optimal Melatonin Dose in Older Adults: A Clinical Review of the Literature
    Pierce, Mackenzie
    Linnebur, Sunny A.
    Pearson, Scott M.
    Fixen, Danielle R.
    SENIOR CARE PHARMACIST, 2019, 34 (07): : 419 - 431
  • [9] Clinical Epidemiology, Risk Factors, and Outcomes of Encephalitis in Older Adults
    Hansen, Michael A.
    Samannodi, Mohammed S.
    Castelblanco, Rodrigo Lopez
    Hasbun, Rodrigo
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (11) : 2377 - 2385
  • [10] Clinical outcomes and complications of enteral nutrition among older adults
    Attanasio, A.
    Bedin, M.
    Stocco, S.
    Negrin, V.
    Biancon, A.
    Cecchetto, G.
    Tagliapietra, M.
    MINERVA MEDICA, 2009, 100 (02) : 159 - 166